nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Burden of cytogenetically abnormal plasma cells in light chain amyloidosis and their prognostic relevance
|
Kim, Seon Young |
|
2016 |
44 |
C |
p. 45-52 8 p. |
artikel |
2 |
Down-regulation of EZH2 expression in myelodysplastic syndromes
|
Cabrero, Monica |
|
2016 |
44 |
C |
p. 1-7 7 p. |
artikel |
3 |
Editorial board and publication information
|
|
|
2016 |
44 |
C |
p. IFC- 1 p. |
artikel |
4 |
Effects of the combination of decitabine and homoharringtonine in SKM-1 and Kg-1a cells
|
Geng, Suxia |
|
2016 |
44 |
C |
p. 17-24 8 p. |
artikel |
5 |
Evaluation of gemtuzumab ozogamycin associated sinusoidal obstructive syndrome: Findings from an academic pharmacovigilance program review and a pharmaceutical sponsored registry
|
Magwood-Golston, Jametta S. |
|
2016 |
44 |
C |
p. 61-64 4 p. |
artikel |
6 |
Homoharringtonine, aclarubicin and cytarabine (HAA) regimen as the first course of induction therapy is highly effective for acute myeloid leukemia with t (8;21)
|
Zhu, Hong-Hu |
|
2016 |
44 |
C |
p. 40-44 5 p. |
artikel |
7 |
SF3B1-mutated myelodysplastic syndrome with ring sideroblasts harbors more severe iron overload and corresponding over-erythropoiesis
|
Zhu, Yang |
|
2016 |
44 |
C |
p. 8-16 9 p. |
artikel |
8 |
Splenic marginal zone lymphoma: Prognostic factors, role of watch and wait policy, and other therapeutic approaches in the rituximab era
|
Perrone, Salvatore |
|
2016 |
44 |
C |
p. 53-60 8 p. |
artikel |
9 |
The prognostic significance of CD45 expression by clonal bone marrow plasma cells in patients with newly diagnosed multiple myeloma
|
Gonsalves, Wilson I. |
|
2016 |
44 |
C |
p. 32-39 8 p. |
artikel |
10 |
Treatment of CD30-positive systemic mastocytosis with brentuximab vedotin
|
Borate, Uma |
|
2016 |
44 |
C |
p. 25-31 7 p. |
artikel |